These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19895367)

  • 21. Microenvironmental pH and microviscosity inside pH-controlled matrix tablets: an EPR imaging study.
    Siepe S; Herrmann W; Borchert HH; Lueckel B; Kramer A; Ries A; Gurny R
    J Control Release; 2006 May; 112(1):72-8. PubMed ID: 16476499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absorption of oral lornoxicam in healthy volunteers using a granular formulation in comparison with standard tablets.
    Bareggi SR; Gambaro V; Valenti M; Benvenuti C
    Arzneimittelforschung; 1997 Jun; 47(6):755-7. PubMed ID: 9239455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets.
    Dvorácková K; Rabisková M; Masteiková R; Muselík J; Krejcová K
    Drug Dev Ind Pharm; 2009 Aug; 35(8):930-40. PubMed ID: 19274510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of khaya gum as a directly compressible matrix system for controlled release.
    Odeku OA; Fell JT
    J Pharm Pharmacol; 2004 Nov; 56(11):1365-70. PubMed ID: 15525442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of lornoxicam in man.
    Hitzenberger G; Radhofer-Welte S; Takacs F; Rosenow D
    Postgrad Med J; 1990; 66 Suppl 4():S22-7. PubMed ID: 2284217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and evaluation of baicalin-containing in situ pH-triggered gelling system for sustained ophthalmic drug delivery.
    Wu H; Liu Z; Peng J; Li L; Li N; Li J; Pan H
    Int J Pharm; 2011 May; 410(1-2):31-40. PubMed ID: 21397671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets.
    Bendas ER; Christensen JM; Ayres JW
    Drug Dev Ind Pharm; 2010 Apr; 36(4):393-404. PubMed ID: 19740039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of formulation parameters on the drug release and floating properties of gastric floating two-layer tablets with acetylsalicylic acid.
    Hasçiçek C; Yüksel-Tilkan G; Türkmen B; Ozdemir N
    Acta Pharm; 2011 Sep; 61(3):303-12. PubMed ID: 21945909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation and evaluation of novel coated floating tablets of bergenin and cetirizine dihydrochloride for gastric delivery.
    He S; Li F; Zhou D; Du J; Huang Y
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1280-8. PubMed ID: 22206469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulations of zero-order, pH-dependent, sustained release matrix systems by ionotropic gelation of alginate-containing mixtures.
    Moroni A; Drefko W; Thone G
    Drug Dev Ind Pharm; 2011 Feb; 37(2):216-24. PubMed ID: 20973612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. pH-independent sustained release matrix tablet containing doxazosin mesylate: effect of citric acid.
    Cha KH; Tran TH; Kim MS; Kim JS; Park HJ; Park J; Cho W; Hwang SJ
    Arch Pharm Res; 2010 Dec; 33(12):2003-9. PubMed ID: 21191766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carboxymethyl starch and lecithin complex as matrix for targeted drug delivery: I. Monolithic mesalamine forms for colon delivery.
    Mihaela Friciu M; Canh Le T; Ispas-Szabo P; Mateescu MA
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):521-30. PubMed ID: 23562535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hot melt granulation: a facile approach for monolithic osmotic release tablets.
    Panda RR; Tiwary AK
    Drug Dev Ind Pharm; 2012 Apr; 38(4):447-61. PubMed ID: 21954892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and evaluation of a time-specific pulsatile-release tablet of aceclofenac: a solution for morning pain in rheumatoid arthritis.
    Qureshi J; Ahuja A; Baboota S; Chutani K; Jain S; Ali J
    Methods Find Exp Clin Pharmacol; 2009; 31(1):15-23. PubMed ID: 19357794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of percolation theory in the study of an extended release Verapamil hydrochloride formulation.
    Gonçalves-Araújo T; Rajabi-Siahboomi AR; Caraballo I
    Int J Pharm; 2008 Sep; 361(1-2):112-7. PubMed ID: 18621491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Floating matrix dosage form for dextromethorphan hydrobromide based on gas forming technique: in vitro and in vivo evaluation in healthy volunteers.
    Hu L; Li L; Yang X; Liu W; Yang J; Jia Y; Shang C; Xu H
    Eur J Pharm Sci; 2011 Jan; 42(1-2):99-105. PubMed ID: 21050887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compressed biodegradable matrices of spray-dried PLGA microspheres for the modified release of ketoprofen.
    Gavini E; Sanna V; Juliano C; Giunchedi P
    J Microencapsul; 2003; 20(2):193-201. PubMed ID: 12554374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of powder mixtures and hydrophilic gastroretentive drug delivery systems containing zinc acetate and sodium bicarbonate.
    Baki G; Bajdik J; Pintye-Hódi K
    J Pharm Biomed Anal; 2011 Mar; 54(4):711-6. PubMed ID: 21109379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a multi particulate extended release formulation for ZK 811 752, a weakly basic drug.
    Kranz H; Le Brun V; Wagner T
    Int J Pharm; 2005 Aug; 299(1-2):84-91. PubMed ID: 15970409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydroxyethyl Pachyman as a novel excipient for sustained-release matrix tablets.
    Zhou X; Wang P; Wang J; Liu Z; Hong X; Xiao Y; Liu P; Hu X
    Carbohydr Polym; 2016 Dec; 154():1-7. PubMed ID: 27577889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.